The last time I spoke about Upstream Bio, Inc. (UPB) it was in a Seeking Alpha article entitled "Upstream Bio: Treating Respiratory Disorders With TSLP Targeting Differentiation." With respect to this ...
– Verekitug provided statistically significant and clinically meaningful reductions in annualized asthma exacerbation rate (AAER) with 100 mg q12 and 400 mg q24 week dosing – – Verekitug also ...
Upstream Bio Inc. UPB shares are up on Thursday following the company’s announcement of a Phase 3 development strategy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results